Infections Are Leading Cause of Hospital Death in Indian Patients with Inflammatory Myopathy
vitalworks / Pixabay

Infections Are Leading Cause of Hospital Death in Indian Patients with Inflammatory Myopathy

  According to a recent article, researchers investigated the cause of deaths in the hospital in patients who were diagnosed with inflammatory myositis in a tertiary care center in Northern…

Continue Reading Infections Are Leading Cause of Hospital Death in Indian Patients with Inflammatory Myopathy
CoVER Study Seeks to Understand COVID-19 Vaccine Impact on Autoimmune Diseases
kfuhlert / Pixabay

CoVER Study Seeks to Understand COVID-19 Vaccine Impact on Autoimmune Diseases

Medical studies are crucial to understand the effect of diseases and treatments on patients. Over the last year and a half, the medical field has distinctly focused on COVID-19, a…

Continue Reading CoVER Study Seeks to Understand COVID-19 Vaccine Impact on Autoimmune Diseases

Patients with Rare Autoimmune Rheumatic Disease Face More Severe COVID-19 Cases

A review of COVID-19 data from the UK shows that patients with rare autoimmune rheumatic disease (RAIRD) face a higher mortality risk, according to an article in Healio. The study,…

Continue Reading Patients with Rare Autoimmune Rheumatic Disease Face More Severe COVID-19 Cases
ACR Convergence 2020: Presentations on KZR-616 for Autoimmune Conditions
https://pixabay.com/photos/student-typing-keyboard-text-woman-849822/

ACR Convergence 2020: Presentations on KZR-616 for Autoimmune Conditions

Since the company was founded, biotechnology company Kezar Life Sciences ("Kezar") has worked to develop therapies for patients with oncologic and autoimmune disorders. Recently, they highlighted a potential treatment, KZR-616,…

Continue Reading ACR Convergence 2020: Presentations on KZR-616 for Autoimmune Conditions
Experimental Drug Earns Orphan Drug Designation for Polymyositis and Dermatomyositis
source: pixabay.com

Experimental Drug Earns Orphan Drug Designation for Polymyositis and Dermatomyositis

According to a story from Biotech 365, the biotechology company Kezar Life Sciences, Inc. recently announced that its experimental therapy KZR-616 has earned Orphan Drug designations from the US Food…

Continue Reading Experimental Drug Earns Orphan Drug Designation for Polymyositis and Dermatomyositis
Researchers Find Effective Biomarker for Predicting Severity of Myositis-Associated Interstitial Lung Disease
source: pixabay.com

Researchers Find Effective Biomarker for Predicting Severity of Myositis-Associated Interstitial Lung Disease

A team of researchers recently evaluated a new biomarker in interstitial lung disease to see whether or not it could predict disease severity and ultimately mortality. The Biomarker Surfactant protein…

Continue Reading Researchers Find Effective Biomarker for Predicting Severity of Myositis-Associated Interstitial Lung Disease
Firma Clinical Research Incorporates Patient “Lived Experience” Into Training Materials
5239640 / Pixabay

Firma Clinical Research Incorporates Patient “Lived Experience” Into Training Materials

According to a story from outsourcing-pharma.com, the company Firma Clinical Research, which provides health care services to patients in clinical trials, has been getting a lot of business lately. This…

Continue Reading Firma Clinical Research Incorporates Patient “Lived Experience” Into Training Materials
Researchers Continue Search for Role of Type-1 Interferon Pathway in Rheumatic Disease
mohamed_hassan / Pixabay

Researchers Continue Search for Role of Type-1 Interferon Pathway in Rheumatic Disease

According to a publication from the Rheumatologist, past studies have suggested that type 1 interferons may play a significant role in determining susceptibility to several classic connective tissue diseases. Although…

Continue Reading Researchers Continue Search for Role of Type-1 Interferon Pathway in Rheumatic Disease